Products
Companies
News
About
About
FAQ
Contact
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
ClearRead Xray - Bone Suppress
ClearRead Xray - Bone Suppress
Riverain Technologies
ClearRead Bone Suppress removes ribs and clavicles from a standard chest X-ray, providing a soft tissue image, allowing clinicians to see more.
Information source:
Vendor
Last updated:
June 20, 2022
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
ClearRead Xray - Bone Suppress
Company
Riverain Technologies
Subspeciality
Chest
Modality
X-ray
Disease targeted
Lung cancer
Key-features
Bone suppression
Suggested use
During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand)
Technical Specifications
Data characteristics
Population
Adult, not pediatric
Input
PA/AP chest view, showing both lungs
Input format
DICOM
Output
Enhanced image: reduced noise, equalized tissue, and suppressed bones (ribs and clavicles)
Output format
DICOM Secondary Capture
Technology
Integration
Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment
Locally on dedicated hardware, Locally virtualized (virtual machine, docker)
Trigger for analysis
Automatically, right after the image acquisition
Processing time
1 - 10 minutes
Regulatory
Certification
CE
Certified, Class IIa
, MDR
FDA
510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)
ClearRead Xray | Bone Suppress is indicated to generate an enhanced, secondary digital radiographic image of the chest. The enhanced AP or PA image of the chest provides improved visibility of the lung parenchyma through bone suppression and tissue equalization, and may facilitate discerning the presence or absence of nodules. The Bone Suppress image provides adjunctive information and is not a substitute for the original PA/AP image. This device is intended to be used by trained professionals, such as physicians, radiologists, and technicians, on patients at risk of having lung nodules and is not intended to be used on pediatric patients.
Market
Market presence
On market since
11-2008
Distribution channels
Sectra Amplifier Store, Aidoc aiOS, Volpara Health, GE Healthcare, syngo.via
Countries present (clinical, non-research use)
13
Paying clinical customers (institutes)
200+
Research/test users (institutes)
7
Pricing
Pricing model
Subscription, One-time license fee
Based on
Number of analyses
Evidence
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers